WisdomTree (WETF) Adopts Poison Pill Following 'Rapid Accumulation' of Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
WisdomTree Adopts Limited Duration Stockholder Rights Plan
March 14, 2022 5:30 AM EDTStockholders to Vote on Rights Plan at 2022 Annual Meeting
NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- WisdomTree Investments, Inc. (WisdomTree or the Company) (NASDAQ: WETF), an exchange-traded fund (ETF) and exchange-traded product (ETP) sponsor and asset manager, today announced that its Board of Directors (the Board) adopted a limited duration stockholder rights plan (the rights plan).
The Board adopted the rights plan in response to the recent rapid accumulations of significant portions of WisdomTree outstanding common stock. It is intended to protect WisdomTree and its stockholders from efforts by a single stockholder or group of... More
